Drug Shortage Report for ELLA
| Report ID | 273839 |
| Drug Identification Number | 02436329 |
| Brand name | ELLA |
| Common or Proper name | ELLA |
| Company Name | LABORATOIRE HRA PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | ULIPRISTAL ACETATE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | ELLA 30MG 1'S UD |
| ATC code | G03AD |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2025-12-09 |
| Estimated end date | 2025-12-23 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-10 |
| Company comments | Packaging material delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 200 AVENUE DE PARIS CHÂTILLON, -- FRANCE 92320 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-12-10 | English | Compare |
| v2 | 2025-12-09 | French | Compare |
| v1 | 2025-12-09 | English | Compare |
Showing 1 to 3 of 3